A new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.
Interesting Engineering on MSN3d
Gold-based drug slows cancer tumor growth by 82%, outperforms chemotherapyA new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.
News Medical on MSN4d
New gold-based drug proves to be more potent than standard chemotherapyA new gold-based drug can slow tumour growth in animals by 82% and target cancers more selectively than standard chemotherapy ...
In this interview, recorded during the Fetch dvm360 conference in Atlantic City, New Jersey, Bergman shared that his lecture ...
While the chemotherapy is awaiting FDA approval for use in humans, Rodriguez saw an opportunity to try the medication in animals. Mauri was the perfect candidate. “So far, his response has been ...
as well as all the others previously performed in chemotherapy-induced peripheral neurotoxicity, although generally based on promising pre-clinical results obtained in animal models 17 ...
The animal’s placenta is packed with proteins ... In tests on patients with breast cancer who were being given chemotherapy drugs doxorubicin (an injection) and cyclophosphamide (a tablet ...
The animal's placenta is packed with proteins ... In tests on patients with breast cancer who were being given chemotherapy ...
Canalevia-CA1, the company's conditionally approved prescription drug for the treatment of chemotherapy-induced ... the quality of life of people and animals undergoing cancer treatment." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback